(Q47586971)

English

Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers

scientific article published in June 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15149786

Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers (English)

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15149786

Salmonella enterica

0 references

Helicobacter pylori

1 reference

based on heuristic

inferred from title

0 references

8

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15149786

Thomas F. Meyer

10

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15149786

author name string

Metzger WG

1

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15149786

Mansouri E

2

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15149786

Kronawitter M

3

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15149786

Diescher S

4

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15149786

Soerensen M

5

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15149786

Hurwitz R

6

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15149786

Bumann D

7

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15149786

Von Specht BU

9

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15149786

language of work or name

0 references

publication date

1 June 2004

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15149786

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15149786

22

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15149786

17-18

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15149786

2273-2277

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15149786

Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.020

7 January 2021

Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.020

7 January 2021

Helicobacter pylori and gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.020

7 January 2021

Safety of oral immunisation with recombinant urease in patients with Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.020

7 January 2021

Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.020

7 January 2021

Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.020

7 January 2021

Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.020

7 January 2021

Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.020

7 January 2021

Antibody-independent protective mucosal immunity to gastric helicobacter infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.020

7 January 2021

Therapeutic immunization against Helicobacter pylori infection in the absence of antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.020

7 January 2021

How CD4(+) T cells may eliminate extracellular gastric Helicobacter?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.020

7 January 2021

Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.020

7 January 2021

Vaccine-induced protection against Helicobacter pylori in mice lacking both antibodies and interleukin-4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.020

7 January 2021

Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.020

7 January 2021

Vaccination of mice with live recombinant Salmonella typhimurium aroA against H. pylori: parameters associated with prophylactic and therapeutic vaccine efficacy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.020

7 January 2021

Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.020

7 January 2021

The Antibody Response to an Oral Ty21a-Based Typhoid-Cholera Hybrid Is Unaffected by Prior Oral Vaccination with Ty21a

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.020

7 January 2021

Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.020

7 January 2021

The immune response to a B-cell epitope delivered by Salmonella is enhanced by prior immunological experience.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.020

7 January 2021

Oral delivery of foreign antigens by attenuated Salmonella: consequences of prior exposure to the vector strain.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.020

7 January 2021

Impact of vector priming on the immunogenicity of recombinant Salmonella vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.020

7 January 2021

Different profiles of the human immune response to primary and secondary immunization with an oral Salmonella typhi Ty21a vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.020

7 January 2021

Prior immunologic experience potentiates the subsequent antibody response when Salmonella strains are used as vaccine carriers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.020

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2003.11.020

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15149786

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15149786

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47586971&oldid=2160816029"